Search - tctmd.com

Displaying 201 - 213 of 213

Sort: Relevancy | Date

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

News Conference News THT 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

Todd Neale

February 18, 2025

News Daily News

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Caitlin E. Cox

February 14, 2025

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

Presentation THT 2025

Treating Aortic Regurgitation in LVAD Patients - Who, When and How

Presenter: Torsten Vahl

February 12, 2025

Presentation THT Abstracts 2025

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Presenter: Aasim Afzal

February 11, 2025

Presentation THT 2025

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Presenter: Aasim Afzal

February 11, 2025

News Conference News STS 2025

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

Yael L. Maxwell

February 05, 2025

Presentation Miami Valves 2025

Understanding the Tricuspid Regurgitation (Pathologist Perspective)

Presenter: Renu Virmani

January 30, 2025

Presentation Miami Valves 2025

Clinical Trials for Mitral Regurgitation Beyond TEER: Where to Next

Presenter: Jeffrey Popma

January 30, 2025

Presentation Miami Valves 2025

Transcatheter treatment of Aortic Regurgitation

Presenter: Venkatesh Alapati

January 30, 2025

Presentation Miami Valves 2025

Dedicated TAVR Devices for Chronic Aortic Regurgitation

Presenter: Santiago Garcia

January 30, 2025

Presentation Miami Valves 2025

Pathological Insights to the Native Aortic Valve Regurgitation

Presenter: Renu Virmani

January 30, 2025

Advertisement

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Treating Aortic Regurgitation in LVAD Patients - Who, When and How

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

Understanding the Tricuspid Regurgitation (Pathologist Perspective)

Clinical Trials for Mitral Regurgitation Beyond TEER: Where to Next

Transcatheter treatment of Aortic Regurgitation

Dedicated TAVR Devices for Chronic Aortic Regurgitation

Pathological Insights to the Native Aortic Valve Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content